SCHEMBL984183

SCHEMBL984183

C[C@H](O)C(=O)N[C@H]1CC[C@H](NC(=O)c2c[nH]c3c(-c4ccc(F)cc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 5/20 0.37
KDM5A P29375 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
CRHR1 P34998 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
IRAK4 Q9NWZ3 2/20 0.34
IDO1 P14902 1/20 0.34
EIF2S1 P05198 1/20 0.34
EIF2AK3 Q9NZJ5 1/20 0.34
HPGD P15428 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
SYK P43405 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
BMPR1B O00238 1/20 0.33
BMPR1A P36894 1/20 0.33
TGFBR1 P36897 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982180 1.00 BTK (0.37) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL982594 0.91 BTK (0.42) BTKKMT2A
SCHEMBL984517 0.91 BTK (0.39) BTKCRHR1GRIN1GRIN2BACACB
SCHEMBL985750 0.91 BTK (0.39) BTKCRHR1GRIN1GRIN2BACACB
SCHEMBL986391 0.90 CDK9 (0.41) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL985350 0.90 CDK9 (0.41) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL984182 0.89 SMYD3 (0.41) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL981859 0.89 SMYD3 (0.41) BTKKDM5AKDM4CCRHR1ALDH1A1
SCHEMBL982398 0.89 BTK (0.34) BTKALDH1A1IRAK4
SCHEMBL984894 0.88 GRIN1 (0.36) KDM5AKDM4CCRHR1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A BTK 1977/4885KDM5A 263/4885KDM4C 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.